Научный журнал «Вестник науки»

Режим работы с 09:00 по 23:00

zhurnal@vestnik-nauki.com

Информационное письмо
  1. Главная
  2. Архив
  3. Вестник науки от 25 июня 2026 г.
  4. Научная статья № 107
Просмотры  6 просмотров

CLINICAL AND PROGNOSTIC FACTORS ASSOCIATED WITH ATRIAL FIBRILLATION RECURRENCE AFTER CATHETER ABLATION

Abstract: atrial fibrillation remains the most sustained cardiac arrhythmia worldwide and is associated with a substantial risk of ischemic stroke, heart failure, impaired quality of life, and increased mortality. Catheter ablation has become an established rhythm-control strategy for symptomatic patients, however, recurrent atrial fibrillation continues to affect a considerable proportion of individuals despite advances in mapping technologies and ablation techniques. The identification of factors associated with post-ablation recurrence has therefore become an important component of patient selection, individualized treatment planning, and long-term clinical management.This review summarizes current evidence regarding clinical and prognostic determinants of atrial fibrillation recurrence following catheter ablation. Particular attention is given to patient-related characteristics, structural and electrical atrial remodeling, imaging findings, circulating biomarkers, procedural variables, and early post-ablation arrhythmia recurrence. Contemporary studies indicate that atrial fibrosis, left atrial enlargement, prolonged atrial fibrillation duration, persistent atrial fibrillation, obesity, diabetes mellitus, obstructive sleep apnea, chronic kidney disease, and elevated inflammatory activity are consistently associated with an increased likelihood of recurrence. Integrating these variables into comprehensive risk assessment may improve patient stratification, optimize procedural outcomes, and facilitate personalized follow-up strategies after catheter ablation.

Keywords: atrial fibrillation, catheter ablation, atrial fibrillation recurrence, prognostic factors, clinical predictors, atrial remodeling, left atrial fibrosis, risk stratification, biomarkers, pulmonary vein isolation.

Introduction. Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia and represents a major challenge for contemporary cardiovascular medicine owing to its increasing global incidence, aging population, and close association with ischemic stroke, heart failure, cognitive decline, and cardiovascular mortality. Beyond its clinical consequences, AF imposes a substantial economic burden on healthcare systems because of recurrent hospitalizations, repeated interventions, and the need for long-term anticoagulation and rhythm-control therapy. During the past decade, catheter ablation has evolved from a treatment reserved for selected symptomatic patients into an established therapeutic strategy capable of improving rhythm control, functional capacity, and quality of life.

Nevertheless, long-term maintenance of sinus rhythm after ablation remains inconsistent, with clinically significant recurrence observed in a considerable proportion of patients despite continuous technological advances and refinement of ablation techniques [1,2]. Recurrence of AF after catheter ablation reflects the complex interaction between patient-specific characteristics and the underlying arrhythmogenic substrate rather than procedural success alone. Structural remodeling of the left atrium, progressive atrial fibrosis, electrical heterogeneity, chronic inflammation, metabolic disorders, obesity, diabetes mellitus, obstructive sleep apnea, chronic kidney disease, and prolonged AF duration have all been implicated in reducing long-term procedural efficacy. At the same time, improvements in electroanatomical mapping, intracardiac imaging, lesion assessment, and energy delivery have substantially enhanced procedural safety while emphasizing the importance of appropriate patient selection.

Consequently, identifying individuals at increased risk of post-ablation recurrence has become an essential component of personalized rhythm-control strategies and informed clinical decision-making [2–4]. Recent investigations have increasingly focused on integrating clinical variables with imaging findings, electrophysiological characteristics, and circulating biomarkers to improve prediction of recurrent arrhythmia following catheter ablation. Multimodal risk assessment models incorporating demographic factors, comorbidities, left atrial morphology, magnetic resonance imaging, echocardiographic parameters, and biomarkers of myocardial fibrosis and inflammation demonstrate greater predictive performance than isolated clinical indicators. Despite these advances, no universally accepted prognostic model has achieved sufficient accuracy for routine clinical implementation, highlighting the continued need to refine individualized risk stratification.

The purpose of this review was to summarize current evidence regarding the clinical and prognostic factors associated with atrial fibrillation recurrence after catheter ablation and to evaluate their potential role in optimizing patient selection, peri-procedural management, and long-term follow-up [4,5]. Materials and Methods. This study was designed as a systematic literature review. A comprehensive search of PubMed/MEDLINE, Scopus, Web of Science, and the Cochrane Library was conducted to identify publications published between January 2020 and May 2026.

The search strategy combined the terms atrial fibrillation, catheter ablation, pulmonary vein isolation, atrial fibrillation recurrence, clinical predictors, prognostic factors, left atrial remodeling, atrial fibrosis, biomarkers, and risk stratification. The initial search yielded approximately 170 publications. After removing duplicates and screening titles, abstracts, and full texts according to predefined eligibility criteria, 17 studies with the highest methodological quality and direct relevance to the review objective were included in the final analysis. Conference abstracts, case reports, duplicate datasets, and studies with insufficient methodological information were excluded.

The selected evidence was synthesized to evaluate the influence of clinical characteristics, structural and electrical atrial remodeling, imaging parameters, circulating biomarkers, and procedural factors on the risk of atrial fibrillation recurrence following catheter ablation. Results. Analysis of the included studies demonstrated that atrial fibrillation (AF) recurrence after catheter ablation remains a common clinical outcome despite continuous improvements in mapping systems, energy delivery, and peri-procedural management. Across contemporary cohorts, recurrent atrial arrhythmia was reported in approximately 20–45% of patients after a single ablation procedure during 12–36 months of follow-up, whereas repeat procedures increased long-term maintenance of sinus rhythm.

The probability of recurrence varied considerably according to baseline clinical characteristics, emphasizing that procedural success is strongly influenced by the biological substrate underlying AF rather than by technical aspects of pulmonary vein isolation alone [6]. Among patient-related variables, increasing age, prolonged AF history, persistent rather than paroxysmal AF, hypertension, diabetes mellitus, obesity, metabolic syndrome, chronic kidney disease, and heart failure consistently emerged as independent predictors of recurrent arrhythmia. Obstructive sleep apnea demonstrated one of the strongest associations with recurrence because repetitive nocturnal hypoxia, sympathetic activation, and atrial pressure overload promote progressive electrical instability. Studies further showed that recurrence risk increased proportionally with cumulative comorbidity burden, indicating that individual cardiovascular risk factors exert additive rather than isolated effects on post-ablation outcomes [6,7].

Structural remodeling of the left atrium represented one of the most reproducible determinants of long-term rhythm control. Enlargement of left atrial diameter and indexed left atrial volume were consistently associated with higher recurrence rates, reflecting advanced remodeling before intervention. Patients with larger atrial dimensions exhibited lower rates of durable pulmonary vein isolation and greater susceptibility to non-pulmonary vein triggers. Echocardiographic evidence of impaired left atrial reservoir function and reduced atrial strain further identified individuals with advanced mechanical dysfunction even before marked chamber enlargement became apparent [7,8].

Cardiac magnetic resonance imaging substantially refined risk stratification by allowing direct visualization of atrial fibrosis through late gadolinium enhancement. Multiple studies demonstrated that increasing fibrosis burden was independently associated with recurrent AF after catheter ablation regardless of AF subtype. Extensive fibrotic remodeling reduces electrical homogeneity, promotes conduction slowing, and facilitates multiple re-entry circuits capable of maintaining arrhythmia despite successful pulmonary vein isolation. Likewise, electroanatomical mapping consistently showed that extensive low-voltage areas corresponded to advanced atrial remodeling and significantly increased the likelihood of late recurrence [9–11].

Additional imaging-derived parameters have further expanded prognostic assessment. Increased left atrial appendage volume, reduced appendage emptying velocity, impaired left atrial strain, and decreased reservoir function were all associated with diminished long-term procedural efficacy. These parameters frequently identified patients with advanced atrial mechanical dysfunction even when conventional measurements such as left atrial diameter remained only mildly abnormal. The integration of echocardiographic and cardiac magnetic resonance findings therefore provides a more comprehensive assessment of atrial remodeling than either modality alone and improves identification of patients at high risk for recurrent arrhythmia [10–13].

Inflammatory activation and myocardial fibrosis have also emerged as important biological contributors to AF recurrence. Elevated concentrations of C-reactive protein, soluble ST2, transforming growth factor-β, galectin-3, and other markers of extracellular matrix remodeling have been linked to progressive atrial fibrosis and impaired maintenance of sinus rhythm after ablation. Increased inflammatory activity enhances fibroblast activation, collagen deposition, and electrical conduction heterogeneity, thereby facilitating re-initiation of atrial arrhythmias despite technically successful lesion formation. Several studies additionally reported independent associations between composite inflammatory indices derived from routine blood tests and recurrent AF during follow-up [14–17].

Procedural characteristics remained clinically relevant but were generally less predictive than pre-existing atrial substrate. Durable circumferential pulmonary vein isolation continues to represent the cornerstone of rhythm control, however, pulmonary vein reconnection, incomplete lesion continuity, residual conduction gaps, and non-pulmonary vein triggers remain important mechanisms of recurrence. Contemporary contact-force sensing catheters, high-density electroanatomical mapping, and optimized lesion indices have improved procedural durability, although their benefits are substantially attenuated in patients with advanced structural remodeling and diffuse atrial fibrosis [11–13]. The reviewed evidence indicates that post-ablation recurrence is best understood as the consequence of cumulative interactions among clinical characteristics, structural remodeling, biological activity, and procedural factors rather than the influence of any single predictor.

Risk prediction models incorporating demographic variables, AF phenotype, left atrial morphology, magnetic resonance imaging findings, echocardiographic functional parameters, and circulating biomarkers consistently demonstrated superior prognostic performance compared with isolated clinical indicators. These findings support a multimodal approach to patient selection and individualized follow-up aimed at improving long-term rhythm outcomes after catheter ablation [13–17]. Discussion. The findings of the present review indicate that recurrence of atrial fibrillation after catheter ablation should not be regarded solely as a consequence of procedural limitations.

Instead, it reflects the biological complexity of the arrhythmogenic substrate that has developed before intervention. Although pulmonary vein isolation remains the cornerstone of rhythm-control therapy, durable maintenance of sinus rhythm is largely determined by the extent of structural and electrical remodeling already present within the atrial myocardium. This concept explains why patients with apparently successful procedures may still experience recurrent arrhythmia despite complete acute pulmonary vein isolation, whereas individuals with limited atrial remodeling frequently achieve sustained long-term rhythm control after a single intervention [6–9]. One of the most consistent observations across contemporary studies is the dominant prognostic value of left atrial remodeling.

Enlargement of the left atrium, impairment of atrial mechanical function, extensive low-voltage areas, and magnetic resonance evidence of atrial fibrosis appear to represent different manifestations of the same pathological process rather than independent predictors. Progressive fibrosis alters myocardial architecture, disrupts cell-to-cell electrical coupling, and creates areas of heterogeneous conduction that facilitate re-entry even after elimination of pulmonary vein triggers. Consequently, imaging assessment has evolved beyond simple anatomical measurements toward comprehensive characterization of atrial tissue integrity and function, providing substantially greater prognostic information for clinical decision-making [9–13]. The available evidence also highlights that systemic comorbidities actively contribute to atrial remodeling rather than merely coexist with atrial fibrillation.

Obesity, diabetes mellitus, hypertension, chronic kidney disease, and obstructive sleep apnea promote persistent inflammatory activation, oxidative stress, neurohormonal dysregulation, and extracellular matrix remodeling, thereby accelerating fibrotic transformation of the atrial myocardium. From a clinical perspective, these observations support the concept that catheter ablation should not be considered an isolated therapeutic procedure but rather one component of comprehensive disease management. Optimization of cardiovascular risk factors before and after ablation may be equally important for long-term rhythm maintenance as procedural success itself [6,7,14–17]. An additional aspect deserving attention is the increasing role of multimodal risk stratification.

Traditional prediction based on age, AF subtype, and left atrial size alone appears insufficient for accurately identifying patients at highest risk of recurrence. The integration of advanced echocardiographic parameters, cardiac magnetic resonance imaging, electroanatomical mapping, and circulating biomarkers provides a more comprehensive evaluation of atrial substrate and consistently improves prognostic performance. Although currently available prediction models still demonstrate moderate discriminative ability across heterogeneous patient populations, their progressive refinement may facilitate individualized procedural planning, improve patient counseling, and support more personalized follow-up strategies after catheter ablation [10–17]. Conclusion.

Catheter ablation remains one of the most effective rhythm-control strategies for patients with atrial fibrillation, however, recurrence continues to represent a major determinant of long-term treatment success. The available evidence indicates that post-ablation outcomes are primarily influenced by the severity of atrial structural remodeling rather than by procedural factors alone. Persistent atrial fibrillation, prolonged arrhythmia duration, left atrial enlargement, atrial fibrosis, metabolic disorders, obstructive sleep apnea, chronic kidney disease, and sustained inflammatory activity consistently emerge as the principal clinical and prognostic factors associated with recurrent arrhythmia. Contemporary management should therefore extend beyond technical optimization of the ablation procedure and incorporate comprehensive pre-procedural risk assessment together with aggressive modification of reversible cardiovascular risk factors.

The combined use of clinical characteristics, advanced cardiac imaging, electrophysiological findings, and circulating biomarkers offers the greatest potential for individualized patient selection, more accurate prediction of recurrence, and optimization of long-term follow-up. Further prospective multicenter studies are warranted to validate integrated prediction models and establish standardized risk stratification strategies applicable in routine clinical practice.


Полная версия статьи PDF

Номер журнала «Вестник науки» № 6 (99) том 4 ч. 1


Ссылка для цитирования:

Artykbayeva A.M. CLINICAL AND PROGNOSTIC FACTORS ASSOCIATED WITH ATRIAL FIBRILLATION RECURRENCE AFTER CATHETER ABLATION // Журнал «Вестник науки» от 25 июня 2026 г. № 6 (99) том 4 ч. 1. С. 939 - 948. 2026 г. ISSN 2712-8849 // Электронный ресурс: https://www.вестник-науки.рф/article/32310 (дата обращения: 15.11.2026 г.)


Альтернативная ссылка латинскими символами: vestnik-nauki.com/article/32310



Нашли грубую ошибку (плагиат, фальсифицированные данные или иные нарушения научно-издательской этики) ?
- напишите письмо в редакцию журнала: zhurnal@vestnik-nauki.com


Вестник науки © 2026.    16+




* В выпусках журнала могут упоминаться организации (Meta, Facebook, Instagram) в отношении которых судом принято вступившее в законную силу решение о ликвидации или запрете деятельности по основаниям, предусмотренным Федеральным законом от 25 июля 2002 года № 114-ФЗ «О противодействии экстремистской деятельности» (далее - Федеральный закон «О противодействии экстремистской деятельности»), или об организации, включенной в опубликованный единый федеральный список организаций, в том числе иностранных и международных организаций, признанных в соответствии с законодательством Российской Федерации террористическими, без указания на то, что соответствующее общественное объединение или иная организация ликвидированы или их деятельность запрещена.